cilostazol

Cilostazol is a small molecule antiplatelet agent and vasodilator used for the symptomatic relief of intermittent claudication, a condition characterized by leg pain due to poor circulation. It works by inhibiting platelet aggregation and dilating blood vessels, thereby improving blood flow to the legs and increasing walking distance before pain occurs. Cilostazol is a quinolinone derivative that inhibits both primary and secondary platelet aggregation and reduces calcium-induced contractions in vascular smooth muscle. It is primarily indicated for patients with peripheral arterial disease experiencing intermittent claudication[1][2][7]. Developed by: Otsuka Pharmaceutical

Brand names

Pletal

Other names

cilostazolumcilostazole